Local and systemic cytokine responses during experimental human influenza A virus infection. Relation to symptom formation and host defense

The Journal of Clinical Investigation
F G HaydenS E Straus

Abstract

To further understand the role of cytokine responses in symptom formation and host defenses in influenza infection, we determined the levels of IL-1beta, IL-2, IL-6, IL-8, IFN-alpha, TGF-beta, and TNF-alpha in nasal lavage fluid, plasma, and serum obtained serially from 19 volunteers experimentally infected with influenza A/Texas/36/91 (H1N1) and correlated these levels with various measures of infection and illness severity. We found that IL-6 and IFN-alpha levels in nasal lavage fluids peaked early (day 2) and correlated directly with viral titers, temperature, mucus production, and symptom scores. IL-6 elevations were also found in the circulation at this time point. In contrast, TNF-alpha responses peaked later (day 3 in plasma, day 4 in nasal fluids), when viral shedding and symptoms were subsiding. Similarly, IL-8 peaked late in the illness course (days 4-6) and correlated only with lower respiratory symptoms, which also occurred late. None of IL-1beta, IL-2, or TGF-beta levels increased significantly. These data implicate IL-6 and IFN-alpha as key factors both in symptom formation and host defense in influenza.

Associated Clinical Trials

References

Jan 1, 1990·Annual Review of Immunology·J Van Snick
Mar 1, 1995·The Journal of Infectious Diseases·T L NoahS Becker
Nov 1, 1993·Immunobiology·T PeschkeD Gemsa
Sep 1, 1993·The Journal of Allergy and Clinical Immunology·H C KaulbachM A Kaliner
Sep 1, 1995·Microbial Pathogenesis·R L Peper, H Van Campen
Dec 1, 1996·The Journal of Allergy and Clinical Immunology·S MatsukuraM Adachi
Jan 30, 1997·The New England Journal of Medicine·J H Hoofnagle, A M di Bisceglie
Jan 21, 1997·Proceedings of the National Academy of Sciences of the United States of America·L P CousensC A Biron
Feb 3, 1997·The Journal of Experimental Medicine·M RincónR A Flavell

❮ Previous
Next ❯

Citations

Sep 6, 2001·European Journal of Immunology·T HussellP J Openshaw
Jun 26, 2001·Journal of Medical Virology·L KaiserF G Hayden
Aug 2, 2001·Reviews in Medical Virology·M C Zambon
Mar 4, 2009·Pharmaceutical Research·Barbara C BaudnerDerek T O'Hagan
Feb 19, 2008·Bulletin of Mathematical Biology·Michael P Atkinson, Lawrence M Wein
Mar 15, 2002·Current Allergy and Asthma Reports·D A Gentile, D P Skoner
Jun 7, 2003·Current Allergy and Asthma Reports·William J Doyle, Cuneyt M Alper
Apr 22, 2005·Current Allergy and Asthma Reports·William J DoyleDeborah Gentile
May 19, 2006·Central European Journal of Public Health
Apr 26, 2005·Current Infectious Disease Reports·Gary Adam Zeitlin, Melanie Jane Maslow
Feb 9, 2010·Indian Pediatrics·T Jacob John, Mahesh Moorthy
Nov 26, 2003·Antiviral Research·Koen AndriesPhilip R Wyde
Jul 9, 2013·Antiviral Research·David S Fedson
May 19, 2010·Cell Host & Microbe·Jacob E Kohlmeier, David L Woodland
Apr 24, 2013·Journal of Theoretical Biology·Lisa N MurilloAlan S Perelson
Dec 14, 2002·Lancet·Maria Zambon, Wendy Barclay
Mar 16, 2000·Developmental and Comparative Immunology·D L Suarez, S Schultz-Cherry
Jun 20, 2002·Veterinary Immunology and Immunopathology·Kristien Van ReethMaurice Pensaert
May 22, 2003·FEMS Microbiology Letters·Jean-Michel AlonsoMuhamed-Kheir Taha
May 9, 2000·Veterinary Microbiology·K Van Reeth
Nov 19, 2002·Pediatric Neurology·Tatsuo MasuyamaYuhei Hamasaki
Jun 29, 2006·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·David P SkonerWilliam J Doyle
May 31, 2001·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·D A GentileD P Skoner
Oct 10, 2003·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·Deborah A GentileDavid P Skoner
Dec 30, 1999·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·L KaiserF G Hayden
Mar 5, 2003·Trends in Molecular Medicine·Stephan LudwigThorsten Wolff
Sep 24, 2013·Nature Medicine·Saranya SridharAjit Lalvani
Jun 6, 2008·Nature Reviews. Microbiology·Nicholas C Grassly, Christophe Fraser
Jul 30, 2009·The Journal of Biological Chemistry·Jean François RossignolM Gabriella Santoro
Apr 12, 2012·The Journal of Biological Chemistry·Bastien MangeatVincent Piguet
Jun 17, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Jeannette GuarnerSherif R Zaki
Aug 23, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·N LeeJ J Y Sung
Feb 19, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Tasnee ChonmaitreeKelly J Henrickson
May 20, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Stefan Gravenstein
Dec 17, 2009·The Journal of Infectious Diseases·William J DoyleSheldon Cohen
Apr 10, 2010·The Journal of Infectious Diseases·Lincoln L H LauGabriel M Leung
Jan 11, 2000·AIDS Research and Human Retroviruses·A PuriR G Carroll
Apr 13, 2000·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·J A Majde
Feb 26, 2004·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Jorge C G BlancoGregory A Prince
Jan 24, 2007·Biosecurity and Bioterrorism : Biodefense Strategy, Practice, and Science·Thomas V InglesbyD A Henderson

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.